文献速递儿童感染儿童心血管与肾脏

新冠疫情期间MIS-C与川崎病的流行病学及疾病严重程度

Epidemiology and Severity of Illness of MIS-C and Kawasaki Disease During the COVID-19 Pandemic.
PubMed 文献 · Pediatrics · 2023-01-01

该研究基于儿科健康信息系统行政数据库,纳入2020年4月至2022年5月MIS-C和川崎病住院患儿,比较两种疾病的休克发生率及MIS-C严重程度随时间的变化。结果显示MIS-C住院患儿休克比例高于川崎病(38.7% vs 5.1%),且MIS-C患者休克 odds 随时间显著下降(OR 0.98,P < .001),而川崎病无显著变化(OR 1.00,P = .062)。

要点

  • MIS-C住院患儿休克比例显著高于川崎病(38.7% vs 5.1%)。
  • MIS-C患者发生休克的 odds 随时间显著下降(OR 0.98,P < .001)。
  • 川崎病患者休克 odds 随时间无显著变化(OR 1.00,P = .062)。

核心结论

  • MIS-C是与川崎病不同的独立疾病实体,且随着新冠大流行推进,MIS-C相关疾病严重程度下降。

研究设计与样本

  • 基于儿科健康信息系统行政数据库的回顾性研究,纳入2020年4月至2022年5月MIS-C住院4868例和川崎病住院2387例。

主要发现

  • MIS-C住院患儿休克比例为38.7%,川崎病为5.1%。
  • 以时间为固定效应且调整医院聚类和年龄的模型中,MIS-C患者休克 odds 随时间显著下降(OR 0.98,P < .001)。
  • 川崎病患者休克 odds 随时间无显著变化(OR 1.00,P = .062)。

关键数值与推荐

  • 主要结局指标为休克,定义为使用血管活性/正性肌力心脏支持或体外膜氧合。
  • 采用广义估计方程比较MIS-C和川崎病休克比例随时间的变化,调整医院聚类和年龄,时间作为固定效应。

临床怎么用

  • 临床应认识到MIS-C较川崎病更易出现休克,需加强血流动力学监测。
  • 新冠大流行后期MIS-C休克风险下降,但仍需根据病情个体化评估。

局限性

  • 研究基于行政数据库,可能存在编码偏倚和漏诊。
  • 未报告疫苗接种状态、治疗差异及长期结局等潜在混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Multisystem inflammatory syndrome in children (MIS-C) is a novel, severe condition following severe acute respiratory syndrome coronavirus 2 infection. Large epidemiologic studies comparing MIS-C to Kawasaki disease (KD) and evaluating the evolving epidemiology of MIS-C over time are lacking. We sought to understand the illness severity of MIS-C compared with KD and evaluate changes in MIS-C illness severity over time during the coronavirus disease 2019 pandemic compared with KD. METHODS: We included hospitalizations of children with MIS-C and KD from April 2020 to May 2022 from the Pediatric Health Information System administrative database. Our primary outcome measure was the presence of shock, defined as the use of vasoactive/inotropic cardiac support or extracorporeal membrane oxygenation. We examined the volume of MIS-C and KD hospitalizations and the proportion of hospitalizations with shock over time using 2-week intervals. We compared the proportion of hospitalizations with shock in MIS-C and KD patients over time using generalized estimating equations adjusting for hospital clustering and age, with time as a fixed effect. RESULTS: We identified 4868 hospitalizations for MIS-C and 2387 hospitalizations for KD. There was a higher proportion of hospitalizations with shock in MIS-C compared with KD (38.7% vs 5.1%). In our models with time as a fixed effect, we observed a significant decrease in the odds of shock over time in MIS-C patients (odds ratio 0.98, P < .001) but not in KD patients (odds ratio 1.00, P = .062). CONCLUSIONS: We provide further evidence that MIS-C is a distinct condition from KD. MIS-C was a source of lower morbidity as the pandemic progressed.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Molloy MJ, Auger KA, Hall M, et al. Epidemiology and Severity of Illness of MIS-C and Kawasaki Disease During the COVID-19 Pandemic. Pediatrics. 2023. PMID: 37791428. doi:10.1542/peds.2023-062101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。